Nonalcoholic fatty liver diseases (NAFLD) represent a set of liver disorders progressing from
steatosis to steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma, which induce …

Nonalcoholic fatty liver disease (NAFLD) is a major health issue throughout the world.
However, no validated treatments for NAFLD are currently available. In‐depth studies have …

Nonalcoholic fatty liver disease (NAFLD), which is the most prevalent hepatic disorder
worldwide, affecting 25% of the general population, describes a spectrum of progressive …

Nonalcoholic fatty liver disease (NAFLD) is a constellation of progressive liver disorders that
are closely related to obesity, diabetes, and insulin resistance and may afflict over 70 million …

Nonalcoholic fatty liver disease (NAFLD) is a typical chronic liver disease highly correlated
with metabolic syndrome. Growing prevalence of NAFLD is supposed to be linked with the …

Purpose To investigate the protective mechanisms of an 85% pure extract of (−)
epigallocatechin gallate (EGCG) in the development of fibrosis, oxidative stress and …

Nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disease, is a
multifactorial disease resulting from the interaction between environment, genetic …

Nonalcoholic fatty liver disease (NAFLD) represents one of the most common chronic liver
diseases in the world. It has been reported that epigallocatechin‐3‐gallate (EGCG) plays …

Ethnopharmacological relevance Plants are a natural treasure trove; their secondary
metabolites participate in several pharmacological processes, making them a crucial …

Green tea polyphenols have numerous functions including antioxidation and modulation of
various cellular proteins and are thus beneficial against metabolic diseases including …